In our present study, bioinformatics analysis and experimental method verification were used in combination to confirm that miR-495 directly targeted HGF and c-MET mRNA in CRC cells as well as in cetuximab-treated CRC patients whose tumours had progressed. Here, HGF is linked to neoplasm.